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The activity of glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) embedded in the phosphoribulokinase
(PRK)GAPDHCP12 complex was increased 2–3-fold by
reducing agents. This occurred by interaction with PRK
as the cysteinyl sulfhydryls (4 SH/subunit) of GAPDH
within the complex were unchanged whatever the redox
state of the complex. But isolated GAPDH was not acti-
vated. Alkylation plus mass spectrometry also showed
that PRK had one disulfide bridge and three SH groups
per monomer in the active oxidized complex. Reduction
disrupted this disulfide bridge to give 2 more SH groups
and a much more active enzyme. We assessed the kinet-
ics and dynamics of the interactions between PRK and
GAPDH/CP12 using biosensors to measure complex for-
mation in real time. The apparent equilibrium binding
constant for GAPDH/CP12 and PRK was 14  1.6 nM for
oxidized PRK and 62  10 nM for reduced PRK. These
interactions were neither pH- nor temperature-depend-
ent. Thus, the dynamics of PRKGAPDHCP12 complex
formation and GAPDH activity are modulated by the
redox state of PRK.
Phosphoribulokinase (PRK)1 (EC 2.7.1.19) and glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.13) form
multienzyme complexes. Several multienzyme complexes with
different compositions have been isolated from chloroplasts
(1–21).
The PRKGAPDH core complex is linked to photosynthesis,
as these two enzymes are part of the Benson-Calvin cycle and
use ATP and NADPH produced by the primary reactions of
photosynthesis. PRK catalyzes the ATP-dependent phosphoryl-
ation of ribulose 5-phosphate to form ribulose 1,5-bisphos-
phate, the CO2 acceptor in photosynthetic organisms, and
GAPDH catalyzes the reversible reduction and dephosphoryl-
ation of 1,3-bisphosphoglycerate (BPGA) to glyceraldehyde
3-phosphate using NADPH.
We have purified a complex from the green alga Chlamydo-
monas reinhardtii (10) that is made up of two dimeric PRK and
two tetrameric GAPDH. The protein CP12 (20–22) was found
recently to be associated with this supramolecular edifice (23).
The two enzymes, PRK and GAPDH, may each be obtained in
a free independent state. When they are not associated with
each other they form dimers (PRK) or tetramers (GAPDH).
CP12 is tightly associated with GAPDH (23). The complex can
be dissociated by harsh reduction and reversed by oxidizing
conditions, because the oxidized partners can spontaneously
reform a complex in vitro that is quite similar to the native
state (10). In only a few cases has it been possible to assemble
particles from their separate parts in vitro that resemble the
native complexes (24, 25). The association of these two enzymes
also gives rise to new regulatory properties. PRK and GAPDH
within the complex are regulated by NADP(H) rather than by
NAD(H), whereas the independent stable enzymes are not (26).
Oxidized PRK may be active when associated with GAPDH or
when dissociated from the complex upon dilution (14). We have
also shown that the complex may exist under mild reducing
conditions (12) even if it is dissociated by severe reducing
conditions (DTT concentrations up to 20 mM). But it dissociates
faster upon dilution, as reduction weakens the complex.
Whereas plant enzymes are heterotetrameric (A2B2), algal
GAPDHs are homotetrameric and made up of only A subunits
(27, 28). The B subunit has a C-terminal extension that con-
tains two cysteine residues believed to be involved in the reg-
ulation of the enzyme (29–31). Nonetheless, studies on crude
extracts of Chlamydomonas indicate that the algal enzyme
that lacks these 28 amino acid residues can be activated reduc-
tively by light (32). We have studied the regulation of this
enzyme upon reduction or oxidation in its isolated state or
within the PRKGAPDHCP12 complex to see if this reductive
light activation is explained by the interaction of GAPDH with
its protein partners. The same study was performed on the
other partner, PRK. In previous studies (14) we have fully
characterized the activity of isolated PRK and PRK in the
complex. PRK in the so-called oxidized complex was active as
mentioned above, but this result has been disputed (33), as the
cysteinyl sulfhydryls of PRK in the complex have never been
directly tested. We have therefore used mass spectrometry
coupled with protein chemistry to analyze the cysteinyl sulfhy-
dryl contents of PRK, GAPDH, and CP12 in the complex, what-
ever its redox state.
Finally, we have used a biosensor to study the interaction
between the two enzymes depending on their redox states, as
cellular redox signaling contributes to the control of the Ben-
son-Calvin cycle and many other physiological processes (34).
The qualitative and quantitative aspects of these interactions
have been analyzed.
EXPERIMENTAL PROCEDURES
Materials—Oxidized glutathione, thioredoxin, iodoacetamide, ATP,
ribose 5-phosphate, 3-phosphoglyceric acid, and phosphoribose isomer-
ase were from Sigma, NADPH was from Calbiochem, and other re-
agents were supplied by Roche Molecular Biochemicals. BIAcore 2000
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system, CM5 sensorchips, HBS-EP buffer (10 mM Hepes, 150 mM NaCl,
3.4 mM EDTA, P20 surfactant 0.005% (v/v), pH 7.4), and the amine
coupling kit (N-hydroxysuccinimide, N-ethyl-N-(3-diethylaminopro-
pyl)-carbodiimide, ethanolamine hypochloride) were from BIAcore AB
(Uppsala, Sweden).
Purification of GAPDHCP12PRK and Isolated Forms from C. rein-
hardtii—The complex GAPDHCP12PRK from C. reinhardtii (WM3)
cells grown mixotrophically was purified to apparent homogeneity as
previously described (10). The isolated enzymes (GAPDH/CP12 and
PRK) were obtained by reducing the purified bi-enzyme complex with
20 mM DTT for 1 h. This mixture was loaded onto a DEAE-trisacryl
column equilibrated in buffer supplemented with 5 mM DTT (9, 23). The
resulting purified enzymes were stored at 80 °C in 10% aqueous
glycerol.
Activity Measurements—PRK and GAPDH activities were deter-
mined using a Pye Unicam UV2 spectrophotometer (6, 23). The en-
zymes were reduced by incubating them for 30 min with 20 mM dithi-
othreitol or 10 M reduced thioredoxin at 30 °C. GAPDH was oxidized
with 5 mM oxidized glutathione (5 mM cystine or 2 mM diamide), or 10
M oxidized thioredoxin at 4 °C, with or without 5 mM BPGA or 5 mM
NADP(H). Aliquots were withdrawn at intervals and activity was meas-
ured using NADPH as cofactor. PRK was also oxidized with the same
oxidizing agents but protection experiments were carried out using its
substrates (5 mM ribose 5-phosphate or 5 mM ATP). All experimental
data were fitted to theoretical curves using Sigma plot 5.0. Protein
concentrations were determined by the Bradford method (35).
Native Electrophoresis and Immunoblotting Experiments—Native
PAGE was performed on 4–15% minigels using the Phastsystem appa-
ratus from Amersham Biosciences. Proteins separated by PAGE were
transferred to nitrocellulose filters (0.45 m, Schleicher and Schuell) by
passive diffusion for 24 h. The filters were then immunoblotted with a
rabbit antiserum against spinach PRK. Antibody binding was revealed
using alkaline phosphatase (36).
Mass Spectrometry Analysis of Free Cysteine Residues—The free SH
groups in PRK and GAPDH, both isolated or in the complex, were
quantified by alkylation of the free cysteine residues with iodoacet-
amide prepared as in Ref. 37. The enzymes were incubated with reduc-
ing or oxidizing agents or left untreated. They were alkylated with 100
mM iodoacetamide for 1 h at room temperature in the dark and ana-
lyzed by mass spectrometry MALDI-TOF (Voyager DE Pro mass spec-
trometer from Applied Biosystems). PRK and GAPDH were analyzed
using sinapinic acid (3,5-dimethoxy-4-hydroxycinnaminic acid) as ma-
trix. Samples for analysis were desalted on C18 zip-tips (Millipore) and
eluted in 50% acetonitrile, 0.1% trifluoroacetic acid and 50% water,
0.1% trifluoroacetic acid.
Sensorchip Coupling—PRK or GAPDH that had been treated with
reducing or oxidizing agents were coupled to the sensor chips using the
amine coupling kit and the automated immobilization application wiz-
ard included in the BIAcore software to give a coupling level of around
100 resonance units. One flow cell of each CM5 sensor chip served as
negative control and was used to subtract the bulk refractive index.
Interaction Cycles—We studied the interaction of GAPDH with flow
cells coupled to the various PRK in SPR experiments at 20 l/min in
HBS running buffer plus 0.1 mM NAD. In each interaction run, a given
concentration was injected for 180 s to record the association phase to
the flow cells, after which buffer was injected for 180 s to record the
dissociation phase. Last, 10 l of 10 mM glycine, pH 3, were injected to
regenerate the flow cells. The whole process was automated, and we
performed multiple interaction runs with different GAPDH concentra-
tions. We checked that there was no mass transfer. The sensorgrams
were processed by subtracting the corresponding reference flow cell
sensorgram to remove contributions because of base-line drift, bulk,
and nonspecific interactions. The reverse experiments were performed
by immobilizing GAPDH and injecting different concentrations of PRK.
Theory—The analyte in the injected sample interacts with ligand
immobilized on the sensor surface to give the association phase, which
continues until a steady state is reached and association and dissocia-
tion rates are in equilibrium. The analyte begins to dissociate as soon as
injection is stopped and replaced by buffer. The association and disso-
ciation phases can be used to derive kinetic constants. Assuming pseu-
do-first order kinetics,
AB-|0
kd
ka
AB (Eq. 1)
the rate of complex formation during analyte injection is given by,
dR
dt
 kaCRmax  (kaC  kdRt) (Eq. 2)
where dR/dt is the rate of change of the SPR signal, ka is the association
rate constant, kd the dissociation rate constant, C is the analyte con-
centration, Rmax the maximum analyte binding capacity in response
units (RU), and Rt is the signal at time t.
The rate of dissociation can be expressed as the following.
dR
dt
  kdRt (Eq. 3)
At equilibrium, association and dissociation rates are equal and the
equilibrium-dissociating constant (Kd) is given by the following.
Kd
kd
ka
(Eq. 4)
Global fittings of the exponential curves (sensorgrams) giving both the
ka and kd values were performed using Biaevaluation 3.1.
RESULTS
Titration of Sulfhydryl Groups within the PRKGAPDH
CP12 Complex—PRK in the complex was alkylated using io-
doacetamide. The Chlamydomonas PRK monomer contained
five cysteine residues (SH) but only three molecules of iodoacet-
amide bound to each PRK monomer within the oxidized com-
plex (mass increment of 168.34 Da). This increase indicated
that there was one disulfide bridge and three free thiol groups
(SH) per monomer. The PRK released by dissociating the com-
plex, the so-called metastable PRK, also had one disulfide
bridge. All five cysteine residues in the PRK monomer were
free when the complex was reduced with 20 mM DTT for 30
min, as shown by the mass increment of 274.36 Da (Fig. 1).
GAPDH and CP12 in the oxidized complex were also alkyl-
ated simultaneously. The four cysteine residues per subunit of
GAPDH (mass increment of 222.7 Da, indicating the binding of
four molecules of iodoacetamide) were all free, but no molecules
of iodoacetamide were bound to CP12. As CP12 contains four
cysteine residues, this indicated that CP12 has two disulfide
bridges when it is present in the oxidized complex. Two popu-
lations of CP12 were found after the complex had been reduced
with 20 mM DTT for 1 h. The CP12 in one was fully reduced
(with 4 SH per monomer titrated with iodoacetamide), whereas
the CP12 in the other was half-reduced (with 2 SH per mono-
mer titrated with iodoacetamide). The fully reduced CP12 was
only obtained after drastic dilution of the complex (100-fold)
followed by reduction with 20 mM DTT for 1 h.
GAPDH Activity in the Reduced Complex—The enzyme ac-
tivity of PRK in the oxidized complex was greatly enhanced by
reduction of its disulfide bridge with DTT. No direct effect of
the reducing agent could be detected as the GAPDH in the
so-called oxidized complex already had 4 SH groups per sub-
unit. Nonetheless, there was a reproducible 2- or 3-fold activa-
tion of the NADPH-dependent activity of GAPDH after reduc-
tion of the complex with DTT or reduced thioredoxins (from 40
to 100 units/mg). The NADH-dependent activity of the complex
was also measured as chloroplast GAPDH is specific for both
NADH and NADPH. This activity decreased from 40 to 17
units/mg, so that the ratio of NADPH/NADH activities in-
creased from 1 to 6 upon reduction. This ratio was constant at
6 for isolated GAPDH (26) (Fig. 2).
GAPDH was no longer activated by reducing agent if the
complex had first been dissociated by dilution. On the other
hand, in vitro reconstitution of this complex (9, 10) using dis-
sociated PRK and GAPDH restored the capacity of GAPDH to
become activated (data not shown).
Treatment of the Complex and Isolated Enzymes with Oxi-
dants—We also treated the reduced complex with oxidant as
the activities of PRK and GAPDH within the complex were
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modulated by reducing agents. The GAPDH activity decreased
by one-half as soon as the reducing agent was removed,
whereas the PRK activity remained constant and stable
throughout the experiment. The GAPDH activity was lost as
soon as the PRK-GAPDH interactions were weakened. This
indeed happened when the reducing agent was removed by
dilution on a desalting column. The oxidant GSSG had no
further effect on the GAPDH or PRK activities of the complex.
However, GAPDH activity was slightly reduced (20%) by a
smaller oxidant like cystine, whereas the activity of the PRK in
the complex was drastically decreased. The loss of PRK activity
was reversible as it was restored by adding DTT, but that of
GAPDH was not.
We used native electrophoresis followed by immunoblotting
with anti-PRK antibody (Fig. 3) to examine the difference be-
tween the effect of cystine and GSSG on PRK activity within the
complex. The cystine appeared to be responsible for the dissoci-
ation of the complex and thus led to oxidation of dissociated PRK,
whereas GSSG treatment left the complex intact. Both 5 mM ATP
and, to a lesser extent, 5 mM ribulose 5-phosphate protected PRK
from oxidation by cystine (data not shown).
Isolated GAPDH and PRK were also treated with oxidant.
All PRK activity was lost by incubation with GSSG or cystine.
DTT restored almost full activity (85%), as expected. Treat-
ment of isolated GAPDH with 5 mM GSSG resulted in a 50%
decrease in activity (Fig. 4) but adding DTT (up to 25 mM) did
not restore any activity. Reduction also failed to restore the
activity of GAPDH incubated with 5 mM cystine. This irreversible
decrease in GAPDH activity was not linked to simple denatur-
ation of the enzyme, as the fluorescence spectrum underwent no
red shift (data not shown). Interestingly, the substrate BPGA
prevented the loss of activity because of oxidation, but NADP(H)
did not (Fig. 4). Oxidized thioredoxin had no effect on isolated
GAPDH activity, unlike GSSG, cystine, or diamide.
The activity of GAPDH within the complex was less severely
inhibited by incubation with cystine than was that of the iso-
lated enzyme, although cystine disrupted the complex. This
could be because of these two forms of GAPDH having different
conformations, as indicated elsewhere (26). We therefore com-
pared the kinetic parameters of the two forms to test this
possibility. Kinetic experiments were carried out with a satu-
rating concentration of NADPH and the concentration of BPGA
was varied (Fig. 5).
The form released from the complex displayed Michaelis-
Menten kinetics unlike the isolated form, which displayed pos-
itive co-operativity (23). The data were fitted to a hyperbola to
estimate the catalytic constant (kcat) and the Km for BPGA. The
kcat was 650  10 s
1 and the Km was 262  11 M. These
parameters were compared with those of the isolated enzyme
(Table I).
Interaction Analysis of PRK and GAPDH/CP12 Using SPR—
We then studied the interaction of PRK with GAPDH using
FIG. 1. MALDI-TOF mass spectra of native oxidized complex
(A), oxidized complex treated with iodoacetamide (B), and re-
duced complex treated with iodoacetamide (C). The concentration
of the bi-enzyme complex in all experiments was 1.3 M.
FIG. 2. Activation/inhibition kinetics of the GAPDH in the bi-
enzyme complex in the presence of DTT. The bi-enzyme complex
(300 nM) was incubated with 10 mM DTT and the NADPH- () or the
NADH- (f) dependent activities were measured. The ratio between the
NADPH- and NADH-dependent activities is shown in the inset. The
bi-enzyme complex concentration in the assay cuvette was 0.6 nM.
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biosensor technology to determine whether the redox state of
PRK altered complex formation.
GAPDH and PRK can both be covalently coupled to the CM5
sensorchip, but the enzymes were each immobilized under dif-
ferent conditions. Amine coupling is based on favorable elec-
trostatic attraction between negative charges of the dextran
carboxylic groups and positive charges on the immobilized li-
gand. Thus, PRK (pI 5.68) was covalently bound using HBS-EP
buffer containing 10 mM acetate, pH 4.8 (immobilization buffer
A), whereas GAPDH (pI 8.6) was covalently bound using
HBS-EP buffer, pH 7.4. We studied the stability of the kinase
under these conditions by preincubating the enzyme in immo-
bilization buffer A for up to 40 min before measuring its activ-
ity. No activity was lost during the time of the Biosensor
experiment.
Reduced PRK was immobilized and measurements at differ-
ent GAPDH concentrations were performed (Fig. 6). These
curves were fitted to a model equivalent to the Langmuir model
for adsorption to a surface (Equation 1). The average apparent
equilibrium dissociation constant was 62  10 nM.
We also studied the interaction of oxidized PRK with differ-
ent amounts of GAPDH. GAPDH from rabbit muscle was also
injected onto oxidized PRK to check specificity. The responses
at equilibrium (Req) for Chlamydomonas and rabbit muscle
GAPDH for their interactions with immobilized oxidized PRK
are reported as a function of their concentrations (Fig. 7). The
data were fitted to the following hyperbola function.
Req
Rmax  [GAPDH]
Kd [GAPDH]
(Eq. 5)
The average apparent equilibrium dissociation constant was
14  1.6 nM for algal GAPDH and 628  1.3 nM for rabbit
muscle GAPDH.
Experiments were also carried out at 25 and 37 °C and at pH
7 or 8 to determine whether temperature or pH affected the
interaction between GAPDH and PRK. No difference was ob-
served. The same dissociation constants were obtained whether
or not GAPDH had been treated with GSSG or DTT.
A range of PRK concentrations were tested with immobilized
GAPDH to obtain an average apparent equilibrium dissocia-
tion constant. The same apparent equilibrium dissociation con-
stants were obtained, as when PRK was immobilized. Only
when PRK was reduced did we find a higher apparent equilib-
rium dissociation constant (62  10 nM).
DISCUSSION
Many enzymes belonging to the Benson-Calvin cycle are
regulated by dark-light transitions via thioredoxins in vivo (38)
(or dithiothreitol in vitro). In particular, thioredoxin (39, 40)
reduces the disulfide between Cys55 and Cys16 of inactive oxi-
dized spinach PRK (41, 42).
We have shown (14) that oxidized PRK from C. reinhardtii
may have some activity when it is associated with GAPDH,
contrary to common belief, but no direct evidence of the regu-
latory disulfide bridge between Cys16 and Cys55 present in
oxidized PRK, was given. We have now used alkylation of the
so-called oxidized complex to show that there is one disulfide
bridge in the PRK monomer. The activity of PRK is greatly
increased when it is reduced, indicating that the Cys16–Cys55
bond is the target.
Another troubling aspect of the activity of oxidized PRK
concerns the P-loop. This contains residues that interact with
the - and -phosphoryls of Mg2-ATP (43). This loop should a
priori be free to move for efficient catalysis. Some data for
bacterial PRK (33, 44) suggest that the Cys16–Cys55 disulfide
bridge found only in the eukaryotic enzymes could immobilize
the P-loop, thereby preventing catalytic turnover. However, it
is worthwhile to pinpoint that there are insertions and dele-
tions in the plant and algal enzymes, such as an insertion of 15
residues after the P-loop of the eukaryotic enzyme that may
modify its mobility even in the presence of the Cys16–Cys55
disulfide bridge. These sulfhydryl groups are also not essential
for catalysis, as a Cys16–Cys55 double mutant of spinach PRK
still has some activity (42, 45). The conformational constraint
imposed by this bond is more likely to be responsible for the
decreased PRK activity than the formation of the disulfide
bridge itself (45). Thus, although the bacterial PRK structure is
a useful model, it may not be wise to extrapolate data obtained
with it to eukaryotic PRKs, especially the eukaryotic enzyme in
a multienzyme complex. Our results indicate that the confor-
mational constraint near the P-loop could be attenuated when
the PRK is within the complex, allowing oxidized PRK to be
active. The interaction of PRK with GAPDH modifies the con-
formation of this enzyme (46) and hence its kinetic properties
(12, 14).
There is now considerable published evidence from NMR
studies that supramolecular edifices (protein-protein or DNA-
protein complexes) appear to be flexible (47, 48). The entropic
cost of the decrease in conformational freedom must be offset,
to some extent, by preserving the flexibility of other regions.
These reports support the assertion made above by the authors,
but only structural data will clarify this point. Our direct
evaluation of the redox status of the regulatory cysteine resi-
dues now clearly shows that oxidized PRK may be catalytically
active. This activity is, however, lower than the activity of the
released metastable form, as the PRK-GAPDH association
hampers the overall flexibility of these enzymes. The released
FIG. 3. Immunoblotting following native PAGE of the bi-en-
zyme complex. The bi-enzyme complex (control, lane 3, 700 ng;
treated with GSSG, lane 1, 660 ng; or with cystine, lane 2, 660 ng) was
electrophoresed under native conditions, then immunoblotting experi-
ments were carried out using antibodies against phosphoribulokinase.
Lane 4 pertains to isolated free phosphoribulokinase (6 g) treated with
oxidized glutathione. C stands for the complex and R for the dissociated
phosphoribulokinase.
FIG. 4. Kinetics of oxidation of isolated GAPDH. The NADPH-
dependent activity of GAPDH incubated with 5 mM GSSG () or 5 mM
GSSG plus 6 mM BPGA (f) was followed over time. The final concen-
tration of GAPDH in the assay cuvette was 5 nM.
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PRK with decreased conformational constraint around the P-
loop, because of a memory effect, and with greater overall
flexibility is thus a better catalyst than the enzyme in the
complex.
Whereas each PRK monomer in the oxidized complex has one
disulfide bridge, all the cysteinyl sulfhydryl groups of GAPDH
are free and CP12 has two disulfide bridges. We found five
cysteinyl sulfhydryl groups per PRK subunit by alkylation
after reduction of the oxidized complex. The GAPDH content of
thiol groups obviously does not change, but two or four thiol
groups become titrated per CP12 monomer. Reduction of the
PRK disulfide bridge is followed by an increase in enzyme
activity, as mentioned above.
Chlamydomonas GAPDH is an A4 homotetramer; the regu-
latory cysteine residues are thus absent (28, 31). Nonetheless,
incubation of a crude extract with DTT increased its enzyme
activity 3-fold (32). Somewhat surprisingly, we saw the same
increase in NADPH-dependent activity for GAPDH when it
was part of the complex, but not for the isolated enzyme. We
therefore proposed (49) that this modulation had a physiologi-
cal role, as the NADPH concentrations are increased in the
light. Our present results also show that reducing the complex
leads to a decrease in the use of NADH.
As titration of the thiol groups in GAPDH in the complex
reveals 4 SH groups whatever the redox state of the complex,
the modulation of GAPDH activity is not linked to disulfide
reduction. Our present finding also indicates that these effects
are linked to heterologous interactions within the complex as
FIG. 5. Steady-state kinetics of
GAPDH within the complex. The bi-
enzyme complex was placed in the reac-
tion mixture containing 0.25 mM NADPH
with BPGA concentrations of 0–1.8 mM
and the appearance of product was mon-
itored. The experimental points were fit-
ted to a hyperbola. The bi-enzyme com-
plex concentration in the assay cuvette
was 0.65 nM.
TABLE I
Kinetic parameters of NADPH-GAPDH released from the complex or isolated
BPGA Hill coefficient kcat
Isolated GAPDHa K0.5  151  13 M 1.5  0.2 223  9 s
1
Released GAPDH Km  262  11 M 650  10 s
1
a The kinetic parameters of the isolated GAPDH were from Ref. 23.
FIG. 6. Plasmon resonance monitor-
ing of GAPDH interaction with PRK
surface. Net sensorgrams (after sub-
tracting the bulk refractive index) were
obtained with immobilized reduced PRK
using 0.14 M (1), 0.29 M (2), 0.44 M (3),
and 0.58 M (4) reduced GAPDH as ana-
lyte. The beginning of the association
phase and the beginning of the dissocia-
tion phase were marked with a and d,
respectively. The experimental data were
analyzed using global fitting assuming
a 1:1 interaction with the Biaevalua-
tion 3.1.
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there is no longer an effect once these interactions are weak-
ened or broken. This supports the idea mentioned above that
new properties may emerge as a consequence of conformation
change within multienzyme complexes. It also shows that the
regulation of an enzyme like PRK may modulate the regulation
of another (GAPDH) via a “domino-like” effect.
We have tested the effect of oxidizing agents on PRK and
GAPDH activities, as oxidized thioredoxin causes the oxidation
of the light-reduced enzymes. Treatment with oxidants caused
the activity of reduced PRK isolated or released from the com-
plex (e.g. using cystine) to decrease. This effect was reversed by
reduction, as expected. The situation is quite different for
GAPDH, as the loss of activity by the isolated enzyme that
follows incubation with oxidized glutathione is very likely be-
cause of a modification of the active site cysteine (Cys156), as it
is well documented for other GAPDHs (50). This is also sup-
ported by protection experiments using BPGA and by the fact
that oxidized thioredoxins have no effect on GAPDH activity.
The inactivation is not reversed by a reducing agent. It has
been suggested that the oxidation of glycolytic enzymes may
introduce an element of strain resulting from the formation of
a disulfide bond, which then causes an irreversible conforma-
tional change, perhaps with displacement of an essential resi-
due from the active site. GAPDH is not significantly inacti-
vated by oxidized glutathione even after dissociation of the
complex, like PRK. This may be because the cysteinyl sulfhy-
dryl in this molecule is less exposed than is that in the isolated
GAPDH. We checked this by measuring the enzyme kinetics of
the isolated GAPDH and of the released form from the complex.
The differences observed with the pseudo-affinity constants for
BPGA clearly support the assertion made above. Thus, GAPDH
retains the conformation it had within the complex (imprint-
ing) even after the physical separation of PRK and GAPDH, so
that the sulhydryl group of the Cys156 is poorly accessible to
oxidized glutathione. This corroborates the imprinting effect
previously reported (12, 13, 26).
Finally, the complex we have purified is a suitable model
with which to study protein-protein interactions, but most of
the information on it stems from in vitro reconstitution exper-
iments. This report, for the first time, describes the use of
Biosensor technology to determine the dynamics of these inter-
actions between PRK and the GAPDHCP12 subcomplex under
different redox states. The dissociation constants between the
PRK and GAPDHCP12 subcomplex are rather low (nM range),
with the lowest value (14  1.6 nM) being obtained with oxi-
dized PRK. The probable conformational change caused by the
chemical modification of GAPDH by oxidation has no influence
on the binding of GAPDH to PRK and vice versa. The SPR
results indicate that these enzymes (PRK and GAPDH/CP12)
may reconstitute the complex under reducing conditions with a
low dissociation constant (62  10 nM) even if complex forma-
tion is sensitive to the redox state of PRK. Our results also
suggest that this complex may form at pH 7, under oxidizing
conditions (dark conditions) or at pH 8, under mild reducing
conditions (light conditions).
To conclude, thiol/disulfide exchange influences the state of
activation of chloroplast PRK, in its isolated form and when it
is part of a complex. On the other hand, the modulation of PRK
activity influences the state of activation of GAPDH via pro-
tein-protein interactions, at least in the alga C. reinhardtii. A
new mode of light regulation could emerge that involves a
“domino effect” and this could well apply to enzymes that are
not direct targets of light.
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